Clinical Trial Update: Azithromycin for Acute Exacerbations Requiring Hospitalization [Phase 3]

View source ↗

Summary

A Phase 3 trial of azithromycin for acute exacerbations requiring hospitalization in COPD was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Azithromycin (azithromycin)

Snippet

Sponsor: Wim Janssens | Conditions: Chronic Obstructive Pulmonary Disease | Phase 3 | Status: TERMINATED